TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Novartis Norge AS
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
1,161,483
|
1,348,254
|
1,375,817 |
Financial expenses |
773
|
866
|
2,074 |
Earnings before taxes |
38,673
|
58,165
|
52,026 |
Total assets |
592,491
|
442,290
|
500,313 |
Current assets |
582,983
|
439,536
|
493,868 |
Current liabilities |
333,794
|
213,552
|
266,799 |
Equity capital |
258,352
|
228,289
|
183,109 |
- share capital |
1,500
![]() |
1,500
![]() |
1,500 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
43.6%
|
51.6%
|
36.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
3.3%
|
4.3%
|
3.8% |
Return on assets (ROA) |
6.7%
|
13.3%
|
10.8% |
Current ratio |
174.7%
|
205.8%
|
185.1% |
Return on equity (ROE) |
15.0%
|
25.5%
|
28.4% |
Change turnover |
-186,771
|
-27,563
|
-6,704 |
Change turnover % |
-14%
|
-2%
|
0% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.